Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection

Journal of the National Cancer Institute

Volumn 90, Issue 21, 1998, Pages 1626-1636

  Schwartz, Stephen M ^a   Daling, Janet R ^c   Doody, David R ^a   Wipf, Gregory C ^a   Carter, Joseph J ^a   Madeleine, Margaret M ^c   Mao, Er Jia ^a   Fitzgibbons, E Dawn ^a   Huang, Shixuan ^a   Beckmann, Anna Marie ^a   McDougall, James K ^b   Galloway, Denise A ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; HUMAN; MAJOR CLINICAL STUDY; MOUTH CANCER; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0032483740     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.21.1626     Document Type: Article

References (58)

1. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
2. Chang F, Syrjanen S, Kellokoski J, Syrjanen K. Human papillomavirus (HPV) infections and their associations with oral disease. J Oral Pathol Med 1991;20:305-17.
3. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983;12:418-24.
4. de Villiers EM, Weidauer H, Otto H, zur Hausen H. Papillomavirus DNA in human tongue carcinomas. Int J Cancer 1985;36:575-8.
5. Loning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 1985;84:417-20.
6. Snijders P, van den Brule A, Meijer C, Walboomers J. HPV and cancer of the aerodigestive tract. Papillomavirus Report 1995;6:157-62.
7. Park NH, Min BM, Li SL, Huang MZ, Cherick HM, Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991;12:1627-31.
8. Liu X, Han S, Baluda MA, Park NH. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene 1997;14: 2347-53.
9. Li SL, Kim MS, Cherrick HM, Doniger J, Park NH. Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens. Carcinogenesis 1992;13:1981-7.
10. Kim MS, Shin KH, Baek JH, Cherrick HM, Park NH. HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N′-nuitro-N-nitrosoguanidine in oral carcinogenesis. Cancer Res 1993;53:4811-6.
11. Shin KH, Min BM, Cherrick HM, Park NH. Combined effects of human papillomavirus-18 and N-methyl-N′-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinog 1994;9: 76-86.
12. Park NH, Gujuluva CN, Baek JH, Cherrick HM, Shin KH, Min BM. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 1995;10:2145-33.
13. Oda D, Bigler L, Lee P, Blanton R. HPV immortalization of human oral epithelial cells: a model for carcinogenesis. Exp Cell Res 1996;226: 164-9.
14. Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996;5:567-75.
15. Cruz IB, Snijders PJ, Steenbergen RD, Meijer CJ, Snow GB, Walboomers JM, et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol 1996;32B:55-62.
16. Van Rensburg EJ, Engelbrecht S, Van Heerden WF, Raubennheimer EJ, Schoub BD. Human papillomavirus DNA in oral squamous cell carcinomas from an African population sample. Anticancer Res 1996;16:969-73.
17. Blot WJ, McLaughlin JK, Devesa SS, Fraumeni JF Jr. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 2nd edition. New York: Oxford University Press: 1996. p. 666-80.
18. Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992;135:1093-102.
19. Dillner J, Knekt P, Schiller JT, Hakulinen T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ 1995;311:1346.
20. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984;120:825-33.
21. Harlow BL, Davis S. Two one-step methods for household screening and interviewing using random digit dialing. Am J Epidemiol 1988;127:857-63.
22. Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, et al. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996;12:1663-8.
23. Brandwein M, Zeitlin J, Nuovo GJ, MacConnell P, Bodian C, Urken M, et al. HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994;7:720-7.
24. Riethdorf S, Friedrich RE, Ostwald C, Barten M, Gogacz P, Gundlach KK, et al. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 1997;26:315-21.
25. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79: 595-604.
26. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990; p. 153-8.
27. Gravitt PE, Manos MM. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. IARC Sci Publ 1992;121-33.
28. Jenison SA, Yu XP, Valentine JM, Koutsky LA, Christiansen AE, Beckmann AM, et al. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J Infect Dis 1990;162:60-9.
29. Beckmann AM, Acker R, Christiansen AE, Sherman KJ. Human papillomavirus infection in women with multicentric squamous cell neoplasia. Am J Obstet Gynecol 1991;165:1431-7.
30. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
31. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
32. Thompson WD. Statistical analysis of case-control studies. Epidemiol Rev 1994;16:33-50.
33. Rothman KJ. Modern epidemiology. Boston: Little. Brown; 1986.
34. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
35. Ochert AS, Boulter AW, Birnbaum W, Johnson NW, Teo CG. Inhibitory effect of salivary fluids on PCR: potency and removal. PCR Methods Appl 1994;3:365-8.
36. Dillner J, Kallings I, Brihmer C, Sikstrom B, Koskela P, Lehtinen M, et al. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996; 173:1394-8.
37. Carter JJ, Koutsky LA, Wipf GC, Christensen DN, Lee SK, Kuypers J, et al. The natural history of human papillomavirus 16 capsid antibodies among a cohort of university women. J Infect Dis 1996;174:927-36.
38. Andersson-Ellstrom A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, et al. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Transm Dis 1996;23:234-8.
39. Carter JJ, Galloway DA. Humoral immune response to human papillomavirus infection. Clin Dermatol 1997;15:249-59.
40. Shah KV, Viscidi RP, Alberg AJ, Helzlsouer KJ, Comstock GW. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. Cancer Epidemiol Biomarkers Prev 1997;6:233-7.
41. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer [published erratum appears in J Natl Cancer Inst 1997; 89:1896]. J Natl Cancer Inst 1997;89:1516-23.
42. Bjorge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, et al. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. Br Med J 1997;315:646-9.
43. Wong DT, Todd R, Tsuji T, Donoff RB. Molecular biology of human oral cancer. Crit Rev Oral Biol Med 1996;7:319-28.
44. Wright SC, Zhong J, Zheng H, Larrick JW. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J 1993;7:1045-51.
45. Maneckjee R, Minna JD. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 1994;5:1033-10.
46. Aoshiba K, Nagai A, Yasui S, Konno K. Nicotine prolongs neutrophil survival by suppressing apoptosis. J Lab Clin Med 1996;127:186-94.
47. Chang KW, Chang CS, Lai KS, Chou MJ, Choo KB. High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989;28:57-61.
48. Watts SL, Brewer EE, Fry TL. Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol 1991;71:701-7.
49. Woods KV, Shillitoe EJ, Spitz MR, Schantz SP, Adler-Storthz K. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med 1993;22:101-8.
50. Holladay EB, Gerald WL. Viral gene detection in oral neoplasms using the polymerase chain reaction. Am J Clin Pathol 1993;100:36-40.
51. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 1995;61:450-4.
52. Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:57-68.
53. Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996;5:541-8.
54. Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T. Anagnostopoulos I, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 1990;43:918-21.
55. Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 1990;45:816-20.
56. Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992; 51:845-50.
57. Andl T, Kahn T, Pfuhl A, Erber R, Conradt C, Klein W, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58: 5-13.
58. Cason J, Kaye JN, Best JM. Non-sexual acquisition of human genital papillomaviruses. Papillomavirus Report 1995;6:1-7.